Page last updated: 2024-10-30

leflunomide and Autosomal Hemophilia A

leflunomide has been researched along with Autosomal Hemophilia A in 1 studies

Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.

Research Excerpts

ExcerptRelevanceReference
"A man (age: 76 years) on prednisone and leflunomide for polymyalgia rheumatica developed spontaneous severe haematomas."3.76[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica]. ( Braunert, L; Bruegel, M; Niederwieser, D; Pfrepper, C; Thiery, J, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braunert, L1
Bruegel, M1
Pfrepper, C1
Thiery, J1
Niederwieser, D1

Other Studies

1 other study available for leflunomide and Autosomal Hemophilia A

ArticleYear
[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
    Hamostaseologie, 2010, Volume: 30 Suppl 1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Cyclophospham

2010